Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabodies: small bispecific antibody fragments.

× No keyword cloud information.

12 in total

1. Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.

Authors: Chan Hyuk Kim; Jun Y Axup; Anna Dubrovska; Stephanie A Kazane; Benjamin A Hutchins; Erik D Wold; Vaughn V Smider; Peter G Schultz
Journal: J Am Chem Soc Date: 2012-06-06 Impact factor: 15.419

2. Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv): the case of the hEx3 diabody.

Authors: Ryutaro Asano; Keiko Ikoma; Ippei Shimomura; Shintaro Taki; Takeshi Nakanishi; Mitsuo Umetsu; Izumi Kumagai
Journal: J Biol Chem Date: 2010-11-19 Impact factor: 5.157

3. Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions.

Authors: S Barth; M Huhn; B Matthey; A Klimka; E A Galinski; A Engert
Journal: Appl Environ Microbiol Date: 2000-04 Impact factor: 4.792

4. Tetravalent single-chain avidin: from subunits to protein domains via circularly permuted avidins.

Authors: Henri R Nordlund; Vesa P Hytönen; Jarno Hörhä; Juha A E Määttä; Daniel J White; Katrin Halling; Eevaleena J Porkka; J Peter Slotte; Olli H Laitinen; Markku S Kulomaa
Journal: Biochem J Date: 2005-12-15 Impact factor: 3.857

5. Comprehensive study of domain rearrangements of single-chain bispecific antibodies to determine the best combination of configurations and microbial host cells.

Authors: Ryutaro Asano; Yuri Kuroki; Sachiko Honma; Mihoko Akabane; Shunsuke Watanabe; Shinzo Mayuzumi; Shuichi Hiyamuta; Izumi Kumagai; Koji Sode
Journal: MAbs Date: 2018-07-09 Impact factor: 5.857

6. Self-assembled antibody multimers through peptide nucleic acid conjugation.

Authors: Stephanie A Kazane; Jun Y Axup; Chan Hyuk Kim; Mihai Ciobanu; Erik D Wold; Sofia Barluenga; Benjamin A Hutchins; Peter G Schultz; Nicolas Winssinger; Vaughn V Smider
Journal: J Am Chem Soc Date: 2012-12-21 Impact factor: 15.419

7. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.

Authors: Ryutaro Asano; Ippei Shimomura; Shota Konno; Akiko Ito; Yosuke Masakari; Ryota Orimo; Shintaro Taki; Kyoko Arai; Hiromi Ogata; Mai Okada; Shozo Furumoto; Masayoshi Onitsuka; Takeshi Omasa; Hiroki Hayashi; Yu Katayose; Michiaki Unno; Toshio Kudo; Mitsuo Umetsu; Izumi Kumagai
Journal: MAbs Date: 2014-10-30 Impact factor: 5.857

Review 8. Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapy.

Authors: Nicholas C Nicolaides; Daniel J O'Shannessy; Earl Albone; Luigi Grasso
Journal: Front Oncol Date: 2014-06-13 Impact factor: 6.244

Review 9. Current progress in innovative engineered antibodies.

Authors: William R Strohl
Journal: Protein Cell Date: 2017-08-18 Impact factor: 14.870

10. Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinity.

Authors: Ryutaro Asano; Keisuke Nagai; Koki Makabe; Kento Takahashi; Takashi Kumagai; Hiroko Kawaguchi; Hiromi Ogata; Kyoko Arai; Mitsuo Umetsu; Izumi Kumagai
Journal: Oncotarget Date: 2018-02-14